Methyl 4-(4-hydroxy-3-methoxyphenyl)-2-methyl-4H-pyrimido[2,1-b][1,3]benzothiazol-3-carboxylate

ID: ALA3618290

PubChem CID: 122190926

Max Phase: Preclinical

Molecular Formula: C20H18N2O3S

Molecular Weight: 366.44

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  COc1cc(C2C(C(C)=O)=C(C)N=C3Sc4ccccc4N32)ccc1O

Standard InChI:  InChI=1S/C20H18N2O3S/c1-11-18(12(2)23)19(13-8-9-15(24)16(10-13)25-3)22-14-6-4-5-7-17(14)26-20(22)21-11/h4-10,19,24H,1-3H3

Standard InChI Key:  GJKGFROXICAQSH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    3.7663    5.2907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4915   -1.3190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4732    1.5389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0387    1.5727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0406    2.7727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7006   -0.6045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7006    0.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2274   -0.6045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2274   -0.6045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1691    3.7891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4684    3.0396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2274    0.8244    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7672    3.7907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4668    6.0399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7372   -0.6045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4732   -1.3190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4915    1.5389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7372    0.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.3190    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.0772    0.9715    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2274    0.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7737   -1.2093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1682    5.2891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1336    6.0360    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1716    5.4339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4660    7.2399    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 12  3  1  0
  6  7  1  0
  9  2  1  0
 13 11  1  0
 17 21  1  0
 10 23  1  0
  1 13  2  0
 21 12  1  0
  3 11  1  0
 12  8  1  0
 18  3  1  0
 15 16  1  0
 18  4  1  0
  2  6  2  0
 19  9  1  0
 11 10  2  0
 23 14  2  0
 21  9  2  0
  8 19  1  0
  4  5  1  0
 18 15  2  0
 14  1  1  0
 16  8  2  0
  7 17  2  0
  4 20  2  0
 15 22  1  0
 24 25  1  0
 23 24  1  0
 14 26  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA3618290

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 366.44

Molecular Weight (Monoisotopic): 366.1038

AlogP: 4.29

#Rotatable Bonds: 3

Polar Surface Area: 62.13

Molecular Species: NEUTRAL

HBA: 6

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 9.92

CX Basic pKa: 1.44

CX LogP: 3.69

CX LogD: 3.68

Aromatic Rings: 2

Heavy Atoms: 26

QED Weighted: 0.88

Np Likeness Score: -0.62

References

1. Chikhale R, Thorat S, Pant A, Jadhav A, Thatipamula KC, Bansode R, Bhargavi G, Karodia N, Rajasekharan MV, Paradkar A, Khedekar P..  (2015)  Design, synthesis and pharmacological evaluation of pyrimidobenzothiazole-3-carboxylate derivatives as selective L-type calcium channel blockers.,  23  (20): [PMID:26385444] [10.1016/j.bmc.2015.09.009]

Source

Source(1):

• Scientific Literature